STAT editors and reporters review the widespread impact of grant cuts, layoffs and policy changes — and also discuss recent ...

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Indeed, shares of the three ...

Eli Lilly CEO Dave Ricks urged the Trump administration to move fast on foreign trade ... But he warned an expansion on tariffs or retaliatory tariffs would have a negative impact on not just Lilly ...

Over the last couple of years, one of the best pharma stocks to own has been Eli Lilly ( LLY -3.19%). But now, an investment in Lilly may not look so enticing as the possibility of more tariffs loom.

Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on ...

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

President Trump recently warned big drugmakers that ... the president warned that a "tariff wall" is coming. Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products ...

One of the more interesting aspects about President Donald Trump's recent tariffs is that ... one of the best pharma stocks to own has been Eli Lilly (NYSE: LLY). But now, an investment in Lilly ...

Johnson & Johnson factored roughly $400 million into its 2025 guidance to account for the impact ... the Trump administration could unleash an even bigger threat than tariffs to AbbVie, Lilly ...